20 (AIDX) Convertible Debt (2025 - 2026)
20's (AIDX) quarterly Convertible Debt came in at $570000.0 in Q1 2026, down 7.97% on a QoQ basis from $619355.0 in Q4 2025.
20 (AIDX) Convertible Debt (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Convertible Debt data on file, last reported at $570000.0 in Q1 2026.
- Quarterly Convertible Debt changed N/A year-over-year to $570000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $570000.0 (changed N/A YoY) and the FY2025 annual result came in at $619355.0, changed N/A from the prior year.
- Convertible Debt retreated to $570000.0 in Q1 2026, from $619355.0 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $619355.0 in Q4 2025 to a low of $570000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | 20 | 5.45 Mn | 903,174.56 | 304,727.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 570,000.00 |
| Dec 31, 2025 | 619,355.00 |